Biomason
Biomason uses biotechnology to produce biocement, replacing Portland cement to cut carbon emissions. Founded in 2012 in North Carolina, the company manufactures and distributes concrete products in Europe and the US.
Company Overview
Biomason, founded in 2012 in North Carolina, specializes in producing biocement through biotechnology. The company's innovative approach replaces Portland cement with a more sustainable alternative that significantly reduces carbon emissions. Biomason operates the Biobeton factory in Denmark, distributing its concrete products throughout the European market.
Biocement Technology
Biomason's biocement technology involves using a biotechnology-driven process to create concrete products without Portland cement. This method not only sequesters carbon but also lowers overall carbon emissions. The production process has been adapted for industrial equipment, allowing for efficient manufacturing at their Biobeton factory in Denmark.
Products
Biomason offers a range of products that meet compressive and flexural strength requirements, including tiles available in both the US and European markets. The company is also developing additional products such as pavers and walls, which are currently in the technology development phase.
Manufacturing and Distribution
Biomason's manufacturing operations are centered at their Biobeton factory in Denmark. This facility is equipped with industrial machinery adapted specifically for biocementation. The products manufactured here are subsequently distributed across the European market, contributing to the region's sustainable construction efforts.
Environmental Impact
Biomason's biocement production process contributes to lower carbon emissions through carbon sequestration. By replacing Portland cement with biocement, the company helps reduce the environmental footprint of construction projects. This pioneering approach addresses the pressing need for more sustainable building materials in the industry.